Luca Guarnera, MD1*, Adam Wahida2*, Carmelo Gurnari, MD, PhD3, Stephan Hutter, PhD4*, Sabine Stainczyk5*, Nakisha D Williams, MBBS1*, Arda Durmaz, PhD6*, Yasuo Kubota, MD, PhD1*, Carlos Bravo-Perez, MD7*, Naomi Kawashima, MD PhD8*, Simona Pagliuca, MD, PhD9, Yimin Huang10*, Thomas Laframboise, PhD11*, Valeria Visconte, PhD12, Wencke Walter, PhD13, Manja Meggendorfer, PhD14, Claudia Haferlach, MD4, Wolfgang Kern, MD4, Frank Westermann5*, Lars Feuerbach, PhD, MSc, BSc15*, Torsten Haferlach, MD4 and Jaroslaw Maciejewski16
1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Institute of Metabolism and Cell death, Neuherberg, Germany
3Cleveland Clinic Foundation, Cleveland, OH
4MLL Munich Leukemia Laboratory, Munich, Germany
5Hopp Children’s Cancer Center, Heidelberg, DEU
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, CLEVELAND, OH
7Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
8Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
9Department of Hematology, Nancy University Hospital, Vandœuvre-lès-Nancy, France, France
10Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH
11Case Western Reserve University, Cleveland, OH
12Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Taussig Cancer Institute, Cleveland, OH
13Munich Leukemia Laboratory, Munich, Germany
14MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
15Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, DEU
16Taussig Cancer Center, Cleveland, OH